Responses
Speaker abstracts 2001
Cytokines and inflammatory mediators
AB0231 Pharmacoeconomic analysis of the treatment of rheumatoid arthritis with leflunomide in comparison with the combination of infliximab and methotrexate
Compose a Response to This Article
Other responses
No responses have been published for this article.